
Title: Celebrating Scientific Success: Atossa Therapeutics Applauds Dr. Tessa Cigler and Weill Cornell Medicine on Receiving a CDC Grant for Advanced Breast Cancer Treatment
Atossa Therapeutics Celebrates Weill Cornell Medicine’s $2.3 Million Grant for Young Breast Cancer Patients Seattle, WA, Feb. 5, 2025 – Atossa Therapeutics, Inc. (Nasdaq: ATOS), a leading clinical-stage biopharmaceutical company specializing in the prevention and treatment of breast cancer, extends its warm congratulations to Dr. Tessa Cigler, esteemed member of Atossa’s Board of Directors, and…